Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;46(2):405-418.
doi: 10.1016/j.ecl.2017.01.006. Epub 2017 Feb 23.

Genetics of Hyperparathyroidism, Including Parathyroid Cancer

Affiliations
Review

Genetics of Hyperparathyroidism, Including Parathyroid Cancer

William F Simonds. Endocrinol Metab Clin North Am. 2017 Jun.

Abstract

Primary hyperparathyroidism (HPT) is a metabolic disease caused by the excessive secretion of parathyroid hormone from 1 or more neoplastic parathyroid glands. HPT is largely sporadic, but it can be associated with a familial syndrome. The study of such families led to the discovery of tumor suppressor genes whose loss of function is now recognized to underlie the development of many sporadic parathyroid tumors. Heritable and acquired oncogenes causing parathyroid neoplasia are also known. Studies of somatic changes in parathyroid tumor DNA and investigation of kindreds with unexplained familial HPT promise to unmask more genes relevant to parathyroid neoplasia.

Keywords: CCND1; CDC73; MEN1; MEN2A; Multiple endocrine neoplasia; Oncogene; RET; Tumor suppressor.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement: The author has no commercial, financial or personal conflict of interest that has inappropriately influenced the content of this article. The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this research.

Figures

Figure 1
Figure 1. Two-hit loss of function mutation of the CDC73/HRPT2 tumor suppressor in parathyroid neoplasia
Benign or malignant parathyroid tumors causing hyperparathyroidism (HPT) can result from two-hit loss of function of the CDC73/HRPT2 tumor suppressor gene according to the Knudson hypothesis (see text). The human CDC73/HRPT2 gene is on chromosome 1 at location 1q25. Upper: In a patient without germline CDC73/HRPT2 mutation, both alleles of CDC73/HRPT2 are initially normal in all parathyroid cells. Subsequent step-wise acquired or somatic inactivation of both alleles in the same parathyroid cell results in clonal expansion that may lead to a sporadic parathyroid tumor. Lower: In a patient with germline CDC73/HRPT2 mutation in one allele, an acquired or somatic DNA mutation at the CDC73/HRPT2 locus of the remaining allele in a parathyroid cell results clonal expansion of that cell that may lead to a benign or malignant parathyroid tumor. Patients with germline CDC73/HRPT2 mutation who develop parathyroid adenomas or cancer can present sporadically (if lacking or unaware of relevant family medical history), or belong to a kindred with familial isolated HPT or the hyperparathyroidism-jaw tumor syndrome (HPT-JT). The presence of the first germline mutation at birth in all parathyroid tissue accelerates the acquisition of two hits within a single parathyroid cell and accounts for the earlier age of disease presentation typical of familial forms of HPT such as HPT-JT.

Similar articles

Cited by

References

    1. Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. Nat Rev Dis Primers. 2016;2:16033. - PMC - PubMed
    1. Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med. 1995;333(4):234–240. - PubMed
    1. Brown EM. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Pract Res Clin Endocrinol Metab. 2013;27(3):333–343. - PubMed
    1. Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158. - PubMed
    1. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer. 2005;5(5):367–375. - PubMed

MeSH terms